Ventyx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Nuss John
Ventyx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Mohan Raju
Ventyx Biosciences | 144: Notice of proposed sale of securities pursuant to Rule 144
Ventyx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Nuss John
Ventyx Biosciences | 4: Statement of changes in beneficial ownership of securities-Officer Mohan Raju
Ventyx Biosciences | EFFECT: Others
Ventyx Biosciences | 424B3: Prospectus
Ventyx Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Point72 Asset Management, L.P.(Less than 0.1%),Point72 Capital Advisors, Inc.(Less than 0.1%), etc.
Ventyx Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Cormorant Asset Management, LP(0%),Bihua Chen(0%)
Ventyx Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Deerfield Mgmt, L.P.(9.50%),Deerfield Management Company, L.P.(9.50%), etc.
Ventyx Biosciences | CORRESP: CORRESP
Ventyx Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.90%)
Ventyx Biosciences | UPLOAD: Others
Ventyx Biosciences | S-3: Registration statement for specified transactions by certain issuers
Ventyx Biosciences | 10-Q: Q3 2024 Earnings Report
Ventyx Biosciences | 8-K: Current report
Ventyx Biosciences | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-The Vanguard Group(4.90%)
Ventyx Biosciences | D: Filing D
Ventyx Biosciences | 8-K: Current report
Ventyx Biosciences | 3: Initial statement of beneficial ownership of securities-Officer Gonzales Roy
No Data